In an 8-K filing with the US Securities and Exchange Commission on June 8, Transgenomic stated that Debra Schneider, chief financial officer, had submitted her resignation. She will leave her post June 16. No interim replacement CFO was named in the filing.
Pairings: Jun 9, 2010
Jun 09, 2010